Targeting residual cardiovascular risk in the statin era: cholesterol or inflammation?

Competing Interests: Conflict of interest G.L. received consultant and speaker fees from Astra Zeneca, Boehringer Ingelheim, Novo Nordisk, Daiichi Sankyo, Sanofi, and Novartis, and grant support (to the Institution) for investigator-initiated research from American Heart Association, Italian National Health Service, and Italian Minister of Education, University and Research. G.L. received grant support (to the Institution) for investigator-initiated research from American Heart Association, Italian National Health Service and Italian Minister of Education, University and Research. She is currently involved in the Research Programs of the Italian Cardiovascular Network. She reports personal fees for speaker bureau from Astra Zeneca, Boehringer Ingelheim, Novo Nordisk, Daiichi Sankyo, Sanofi and Novartis, outside the submitted work. C.P. received consultant and speaker fees from AbbVie, Acticor Biotech, Amgen, Bayer, Eli Lilly, and Tremeau, and grant support (to the Institution) for investigator-initiated research from AIFA (Italian Drug Agency), Bayer, Cancer Research UK and European Commission; he chaired the Scientific Advisory Board of the International Aspirin Foundation, outside the submitted work.